Patient dies in Neurogene’s Phase I/II Rett syndrome trial
A report filed with a US authority discloses that a patient who suffered a severe adverse event during the trial has now died.
Explore our marketing solutions
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
